Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-label, Multi-centered Study to Evaluate the Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia(Phase 4)

NCT02056847 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT02056847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02056847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-label, Multi-centered Study to Evaluate the Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia(Phase 4)
Lead sponsor
JW Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2013
Completion date
May 31, 2017
Enrollment
313 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hba1c level associated with lipid compositions